Thursday, June 28, 2018

Many Americans are struggling to afford their medicines and have important questions about their medicine costs. While biopharmaceutical companies set the list price for a brand medicine, more than one-third is rebated back to payers and the supply chain. Insurers negotiate large rebates, but do not share these discounts with patients who pay a deductible or coinsurance -- a percentage of costs a patient is responsible for paying out of pocket – for their medicine. Ultimately your insurer determines what you pay for your medicine out of pocket.


A recent op-ed appearing in The Detroit News from David A. Ricks, chairman and CEO of Eli Lilly and Co., explores the impact out-of-pocket medicine expenses on patients and offers some solutions.




If you or someone you love needs help paying for medications, please know that there are resources available: The Partnership for Prescription Assistance (PPA) helps connect patients who may qualify with patient assistance programs that provide free or nearly free medicines. For more information, visit